Study of FK463 for the Treatment of Invasive Aspergillosis

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Astellas Pharma Inc
ClinicalTrials.gov Identifier:
NCT00036166
First received: May 8, 2002
Last updated: June 12, 2015
Last verified: June 2015